Monte Rosa Therapeutics, Inc. Common Stock GLUE
$15.50
-2.15%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | 4 | 2026-07-17 | View → |
| 4 | 4 | 2026-07-16 | View → |
| 4 | 4 | 2026-07-07 | View → |
| 4 | 4 | 2026-07-06 | View → |
| 4 | 4 | 2026-07-01 | View → |
| 4 | 4 | 2026-06-30 | View → |
| 4 | 4 | 2026-06-30 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-12 | View → |
| 4 | 4 | 2026-06-12 | View → |
| 4 | 4 | 2026-06-12 | View → |
| 4 | 4 | 2026-06-12 | View → |
| 4 | 4 | 2026-06-12 | View → |
| 4 | 4 | 2026-06-12 | View → |
| 4 | 4 | 2026-06-12 | View → |
| 8-K | 8-K | 2026-06-11 | View → |
| 4 | 4 | 2026-06-02 | View → |
| 4 | 4 | 2026-06-01 | View → |
| 4 | 4 | 2026-05-28 | View → |
| 4 | 4 | 2026-05-26 | View → |
| 4 | 4 | 2026-05-22 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| 4 | 4 | 2026-05-05 | View → |
| DEF 14A | DEF 14A | 2026-04-29 | View → |
| 4 | 4 | 2026-04-15 | View → |
| 4 | 4 | 2026-04-10 | View → |
| 4 | 4 | 2026-04-07 | View → |
| 10-K | 10-K | 2026-03-17 | View → |
| 8-K | 8-K | 2026-03-17 | View → |
| 4 | 4 | 2026-03-05 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-02-24 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $15.50
- Market Cap
- $1.36 billion
- 52-Week Range
- $4.12 – $25.77
- Average Volume
- 1.41 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.